MarketWatch Automation
Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ -0.15% inched 0.29% higher to $170.67 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +0.40% rising 2.13% to 4,210.24 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.13% rising 1.63% to 33,309.51. The stock's rise snapped a four-day losing streak. Johnson & Johnson closed $16.02 below its 52-week high ($186.69), which the company achieved on April 25th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/delayed RHHVF +1.17% rose 0.58% to $334.06, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK -0.47% fell 0.37% to $89.19, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE +0.89% rose 0.34% to $49.95. Trading volume (5.6 M) remained 1.1 million below its 50-day average volume of 6.7 M.
Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.
Add to watchlist
JNJ
Add to watchlist
DJIA
Add to watchlist
RHHVF
Add to watchlist
MRK
Add to watchlist
PFE
